BROKERS CHOICE: ONGC, MARUTI, ADANIPORT, PAYTM, GLANDPHARMA, DIVISLAB, ITC, LICHOUSING, AARTIND

AHMEDABAD, 4 FRBRUARY: અગ્રણી બ્રોકરેજ હાઉસ તથા ફંડ હાઉસ તરફથી પસંદગીના સ્ટોક્સમાં ખરીદી\ વેચાણ\ હોલ્ડ કરવા માટે ભલામણ કરવામાં આવી છે. તે રોકાણકારોના અભ્યાસ માટે અત્રે રજૂ કરીએ છીએ.

Jefferies on ONGC: Maintain Buy on Company, target price at Rs 375 (Positive)

MS on Maruti: Maintain Overweight on Company, target price at Rs 14942 (Positive)

GS on Adani Ports: Maintain Buy on Company, target price at Rs 1560 (Positive)

Nuvama on Divis Lab: Maintain Buy on Company, target price at Rs 6830 (Positive)

Citi on Divis Lab: Maintain Buy on Company, target price at Rs 6850 (Positive)

Bernstein on PayTM: Maintain Outperform on Company, target price at Rs 1100 (Positive)

Citi on LIC Housing: Maintain Buy on Company, raise target price at Rs 851 (Positive)

Nomura on LIC Housing: Maintain Buy on Company, raise target price at Rs 735 (Positive)

HSBC on Aster DM: Maintain Buy on Company, target price at Rs 580 (Positive)

MOSL on Vinati Organics: Maintain Buy on Company, target price at Rs 2600 (Positive)

HSBC on Indian Banks: RBI credit data shows growth under pressure, with weak demand and reduced risk appetite slowing retail loan growth. (Neutral)

Jefferies on Divis Lab: Maintain Neutral on Company, target price at Rs 6280 (Neutral)

GS on Divis Lab: Maintain Neutral on Company, target price at Rs 5925 (Neutral)

Citi on Gland Pharma: Maintain Sell on Company, target price at Rs 1420 (Neutral)

Kotak on Premier Energy: Maintain Sell on Company, raise target price at Rs 840 (Neutral)

Jefferies on LIC Housing: Maintain Buy on Company, cut target price at Rs 700 versus Rs 795 (Neutral)

Nuvama on Aarti Ind: Downgrade to Reduce on Company, cut target price at Rs 396 (Negative)

JP Morgan on Bandhan Bank: Downgrade to Neutral on Company, cut target price at Rs 155 versus Rs 250 (Negative)

Jefferies on Gland Pharma: Maintain Underperform on Company, cut target price at Rs 1350 versus Rs 1630 (Negative)

(Disclaimer: The information provided here is investment advice only. Investing in the markets is subject to risks and please consult your advisor before investing.)

(સ્પષ્ટતા: અત્રેથી આપવામાં આવતી તમામ પ્રકારની માહિતી કોઇપણ પ્રકારે રોકાણ/ ટ્રેડીંગ માટેની સલાહ નથી. બજારોમાં રોકાણ જોખમોને આધીન છે અને રોકાણ કરતા પહેલા કૃપા કરીને તમારા સલાહકારની સલાહ લો.)